Cargando…
Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
BACKGROUND: Patients suffering from high risk stage II colon cancer (CC) may benefit from adjuvant onco-therapy, but additional prognostic markers are needed for better treatment stratification. We investigated the prognostic value of Programmed Death Ligand-1 (PD-L1) in a true population-based coho...
Autores principales: | Eriksen, Ann C., Sørensen, Flemming B., Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373021/ https://www.ncbi.nlm.nih.gov/pubmed/30755167 http://dx.doi.org/10.1186/s12885-019-5345-6 |
Ejemplares similares
-
The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study()
por: Eriksen, Ann C., et al.
Publicado: (2018) -
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
por: Eriksen, Ann Christina, et al.
Publicado: (2018) -
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018) -
Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer
por: Eriksen, Ann C., et al.
Publicado: (2017) -
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
por: Hansen, Torben Frøstrup, et al.
Publicado: (2018)